source
- Nivolumab Plus SOC Therapy Shows Encouraging Disease Control in Grade Group 5 Prostate CancerThe regimen produced a 2-year freedom from biochemical recurrence rate of 90.3% in grade group 5 prostate cancer.onclive · 3mo ago↗ source
- Five Under 5: Top Oncology Videos for the Week of 5/3The top 5 OncLive TV videos of the week cover insights in ovarian cancer, classical Hodgkin lymphoma, pancreatic cancer, melanoma, and myelofibrosis.onclive · 3mo ago↗ source
- Experts wonder ‘Where is the CDC?’ as hantavirus outbreak unfoldsThe CDC is playing an unusually small, and quiet, role in responding to the hantavirus outbreak.STAT · 3mo ago↗ source